Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
Gilles Darcis,
Sophie Bouchat,
Anna Kula,
Benoit Van Driessche,
Nadège Delacourt,
Caroline Vanhulle,
Stéphane De Wit,
Olivier Rohr,
Christine Rouzioux,
Carine Van Lint
Affiliations
Gilles Darcis
Brussels University (ULB), Service of Molecular Virology, Molecular Biology Department, Gosselies, Belgium; Liege University Hospital, Infectious Diseases Service, Liège, Belgium
Sophie Bouchat
Brussels University (ULB), Service of Molecular Virology, Molecular Biology Department, Gosselies, Belgium
Anna Kula
Brussels University (ULB), Service of Molecular Virology, Molecular Biology Department, Gosselies, Belgium
Benoit Van Driessche
Brussels University (ULB), Service of Molecular Virology, Molecular Biology Department, Gosselies, Belgium
Nadège Delacourt
Brussels University (ULB), Service of Molecular Virology, Molecular Biology Department, Gosselies, Belgium
Caroline Vanhulle
Brussels University (ULB), Service of Molecular Virology, Molecular Biology Department, Gosselies, Belgium
Stéphane De Wit
Saint Pierre University Hospital, Infectious Diseases Service, Brussels, Belgium
Olivier Rohr
Strasbourg University, Parasitology and tropical pathologies Institute, Strasbourg, France; Strasbourg University, Louis Pasteur University Institute of Technology Schiltigheim, France
Christine Rouzioux
Necker-Enfants Malades Hospital, Paris-Descartes University, Virology, Paris, France
Carine Van Lint
Brussels University (ULB), Service of Molecular Virology, Molecular Biology Department, Gosselies, Belgium
